Sign Out
One mL solution for injection contains 120 mg of brolucizumab.
Each vial contains 27.6 mg of brolucizumab in 0.23 mL solution. This provides a usable amount to deliver a single dose of 0.05 mL containing 6 mg of brolucizumab.
Brolucizumab is a humanized monoclonal single-chain Fv (scFv) antibody fragment with a molecular weight of ~26 kDa, produced in Escherichia coli cells by recombinant DNA technology.
Excipients/Inactive Ingredients: 10 mM sodium citrate, 5.8% sucrose, 0.02% polysorbate 80 and water for injection and has a pH of approximately 7.2.
Continue with Google